TABLE 3.
Confirmation of seroconversion in five vaccinees who were vaccinated with attenuated LVSa
| Vaccinee | Before vaccination |
After vaccination |
||||
|---|---|---|---|---|---|---|
| ELISA (OD) | ICT | MA titer | ELISA (OD) | ICT | MA titer | |
| 1 | Neg (0.016) | - | Neg | 2.752 | +++ | 1:2,048 |
| 2 | Neg (0.008) | - | Neg | 1.862 | ++ | 1:64 |
| 3 | Neg (0.072) | - | Neg | 2.373 | +++ | 1:512 |
| 4 | Neg (0.034) | - | Neg | 1.809 | +++ | 1:256 |
| 5 | Neg (0.025) | - | Neg | 1.452 | ++ | 1:128 |
a
Postvaccination sera were obtained between 4 and 6 weeks after immunization. MA, microagglutination. OD, optical density; Neg, negative; +++, strongly positive; ++, moderately positive; −, negative.